Search Results
90 results found for "Marc Chabre"
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Let’s dive into the Classified GPCR News from March 25th to March 31st, 2024 GPCR Activation and Signaling
- 📰 GPCR Weekly News, March 18 to 24, 2024
Let’s dive into the Classified GPCR News from March 18th to 24th, 2024 GPCR Activation and Signaling Endpoints In The Phase 3 Pathfndr-2 Study In Acromegaly Patients GPCR Events, Meetings, and Webinars March
- 📰 GPCR Weekly News, March 11 to 17, 2024
on Time-resolved cryo-EM of G-protein activation by a GPCR Remi Janicot, Alex Luebbers, Mikel Garcia-Marcos Let’s dive into the Classified GPCR News from March 11th to 17th, 2024 Adhesion GPCRs ADGRG1, an adhesion Therapeutics announces that is now part of Bristol Myers Squibb GPCR Events, Meetings, and Webinars March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- 📰 GPCR Weekly News, March 4 to 10, 2024
Don't miss out, and mark your calendar! Dr. Let’s dive into the Classified GPCR News from March 4th to 10th, 2024 GPCR Activation and Signaling Glu1022.53 Deciphering the role of GPCRs in obesity pathology for drug development GPCR Events, Meetings, and Webinars March 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference
- 📰 GPCR Weekly News, February 26 to March 3, 2024
GPCR Symposia Mark your calendars! Next week, on March 15th, we are hosting a symposium on GPCR activation and signaling. Mark your calendar; we’re planning a workshop for May 2024 with Dr. Sam Hoare as our instructor. 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference
- Mark Schmeizl - Dr. GPCR Podcast
Our guest is Mark Schmeizl!
- 📰 GPCR Weekly News, March 20 to 26, 2023
Below is your Classified GPCR News at a glance for March 20th to 26th, 2023. Ends tomorrow - March 31st, 2023. (March 30, 2023) NEW Webinar - Antiverse: Engineering the Future of Drug Discovery (March 30, 2023) NEW Molecular Dynamics in Pharma (March 31, 2023) NEW FREE Workshop - Challenges in GPCR Drug Discovery (March 31, 2023) SLAS 2023 Building Biology in 3D Symposium.
- 📰 GPCR Weekly News, March 13 to 19, 2023
Below is your Classified GPCR News at a glance for March 13th to 19th, 2023. Deadline extended to March 31st, 2023. (March 23, 2023) NEW 5th ERNEST GPCR ECI zoominar. (March 30, 2023) SLAS 2023 Building Biology in 3D Symposium.
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCR Symposium event held on March 24th? that we can add it to the list of posters and increase the number of people who can ''stop by'' it on March Below is your Classified GPCR News at a glance for March 6th to 12th, 2023. Deadline extended to March 31st, 2023. GPCR Events, Meetings, and Webinars GEM2023. (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium.
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Also, please mark your calendar for the next Dr. or present a poster, email us at Hello@DrGPCR.com Below is your Classified GPCR News at a glance for March
- 📰 GPCR Weekly News, February 27 to March 5, 2023
GPCR Symposium event held on March 24th. that we can add it to the list of posters and increase the number of people who can ''stop by'' it on March Below is your Classified GPCR News at a glance for February 27th to March 5th, 2023. Deadline extended to March 31st, 2023. GPCR Events, Meetings, and Webinars ERNEST ECI zoominar. (March 9) GEM2023. (March 14-17, 2023). SLAS 2023 Building Biology in 3D Symposium.
- Dr. Mark Connor - Dr. GPCR Podcast
Mark Connor! Learn more about #GPCRs and life as an academic wearing different hats.
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
March 2022 "Geneva, Switzerland, March 7, 2022 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage and development, announced today that it will issue its full-year 2021 financial results on Thursday, March
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
June 2022 "June 15, 2022 06:30 AM EDT - In 2016, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just over $600 million for its fourth fund. Since then, Celniker has helped usher in an additional fund and headed a few startups as interim CEO. Coming on its 15th year, Third Rock Ventures announced its sixth fund today — and largest one by far — at a whopping $1.1 billion. Adding it all up, Third Rock has raised $3.8 billion since its inception. That money has gone to some 60 biotechs, much of it as early funding." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Developments at Aelis Farma Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPCR Symposia Mark your calendars! In just two weeks, on March 15th, we are hosting a symposium on GPCR activation and signaling. GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit. Join Dr. Yamina Berchiche at the 3rd GPCRs Summit in Boston on March 5-7, 2024. Dr. 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition
- 📰 GPCR Weekly News, February 5 to 11, 2024
GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd GPCRs Summit in Boston on March 5-7, 2024. 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |
- 📰 GPCR Weekly News, February 12 to 18, 2024
GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd GPCRs Summit in Boston on March 5-7, 2024. 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |
- 📰 GPCR Weekly News, January 29 to February 4, 2024
GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd GPCRs Summit in Boston on March 5-7, 2024. 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |
- 📰 GPCR Weekly News, January 22 to 28, 2024
GPCR Symposia Our first upcoming symposium on March 15th this year is about GPCR activation and signaling Targeted Drug Discovery Summit Join us at the 3rd GPCRs Targeted Drug Discovery Summit in Boston on March BPS Annual Meeting NEW February 20, 2024 | Career Opportunities in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |
- 📰 GPCR Weekly News, January 15 to 21, 2024
GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit We're partnering again with the 3rd GPCRs - Targeted Drug Discovery Summit in Boston on March 5-7, 2024. SLAS2024 International Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting NEW March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 |
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
March 2022 "March 3, 2022 Susanna Naggie, MD, and Sudarshan Rajagopal, MD, PhD Two School of Medicine
- 📰 GPCR Weekly News, February 13 to 19, 2023
Deadline extended to March 31st, 2023. GPCR Events, Meetings, and Webinars SLAS2023 International Conference and Exhibition (February 25 - March (February 20 - March 3, 2023). (March 2, 2023) GEM2023. (March 14-17, 2023). SLAS 2023 B Building Biology in 3D Symposium.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Deadline extended to March 31st, 2023. SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (February 20 - March 3, 2023). (March 2, 2023) GEM2023. (March 14-17, 2023). SLAS 2023 B Building Biology in 3D Symposium.
- 📰 GPCR Weekly News, January 8 to 14, 2024
GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Exciting news! We're partnering again with the 3rd GPCRs - Targeted Drug Discovery Summit in Boston on March 5-7, 2024 | SLAS2024 International Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Prior to this, Professor Deane was Deputy Executive Chair of the Engineering and Physical Sciences Research
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief Commercial Officer "SAN DIEGO – March 1, 2022 – Crinetics Pharmaceuticals, Inc.
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) – March 15, 2022 – Inversago Pharma Inc.